FDA Inspection 845686 — Novel Laboratories, Inc.

Novel Laboratories, Inc. — FEI 3006271438

The FDA completed an inspection of Novel Laboratories, Inc. on Aug 26, 2013 in Somerset, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 13 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 26, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Somerset, NJ (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
119421 CFR 211.42(c)Defined areas of adequate size for operations
121521 CFR 211.67(b)Written procedures not established/followed
189121 CFR 211.165(f)Failing drug products not rejected
200821 CFR 211.186(a)Written procedures followed
202721 CFR 211.192Investigations of discrepancies, failures
241921 CFR 211.198(a)Complaint Handling Procedure
261921 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
357221 CFR 211.100(b)Procedure Deviations Recorded and Justified
438221 CFR 211.198(b)(2)Written record of complaint to include findings, follow-up
457621 CFR 211.192No written record of investigation
891121 CFR 314.81(b)(1)(ii)Failure to meet specifications

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.